Literature DB >> 7670393

Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation.

M D Eisner1, C S August.   

Abstract

Current knowledge of risk factors for graft-versus-host disease (GVHD) in pediatric bone marrow transplantation is derived from studies focusing primarily on adults. We reviewed 100 pediatric HLA-matched allogeneic marrow transplants to identify donor and recipient factors (age, sex, age mismatch, sex mismatch) associated with increased incidence of acute or chronic GVHD. The incidence of acute (32%) and chronic (29%) GVHD were very low. In univariate analyses, recipient age (P = 0.003), donor age (P = 0.002), donor sex (P = 0.089) and age mismatch (P = 0.018) are related to acute GVHD. Prior acute GVHD (P = 0.0001), recipient age (P = 0.057), donor age (P = 0.016), donor sex (P = 0.01) and sex mismatch (P = 0.024) are associated with chronic GVHD. In multivariate analyses, older donor age (P = 0.003) and female donor sex (P = 0.046) independently predict acute GVHD. Only acute GVHD (P = 0.0001) was independently related to chronic GVHD. When acute GVHD was excluded, older donor age (P = 0.032) and sex mismatch (P = 0.005) predict chronic GVHD. Thus, the incidence of acute and chronic GVHD were very low in our pediatric population, especially in the youngest patients. Older donor age and female donor sex are associated with a higher incidence of acute GVHD. Prior acute GVHD, older donor age and sex mismatch are associated with a higher incidence of chronic GVHD.

Entities:  

Mesh:

Year:  1995        PMID: 7670393

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

3.  Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission.

Authors:  Shohei Mizuno; Masamitsu Yanada; Koji Kawamura; Masayoshi Masuko; Naoyuki Uchida; Yukiyasu Ozawa; Koji Iwato; Kazuteru Ohashi; Kazuhiro Ikegame; Sung-Won Kim; Masatsugu Tanaka; Tetsuya Eto; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Shingo Yano; Akiyoshi Takami
Journal:  Bone Marrow Transplant       Date:  2020-07-31       Impact factor: 5.483

4.  Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model.

Authors:  Cécile Gérard; Nathalie Bleyzac; Pascal Girard; Gilles Freyer; Yves Bertrand; Michel Tod
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

Review 5.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

6.  CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients.

Authors:  Y Koike; S Seki; T Ohkawa; T Kaneko; K Kogawa; S Fujitsuka; H Hiraide; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

7.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Authors:  Mary E D Flowers; Yoshihiro Inamoto; Paul A Carpenter; Stephanie J Lee; Hans-Peter Kiem; Effie W Petersdorf; Shalini E Pereira; Richard A Nash; Marco Mielcarek; Matthew L Fero; Edus H Warren; Jean E Sanders; Rainer F Storb; Frederick R Appelbaum; Barry E Storer; Paul J Martin
Journal:  Blood       Date:  2011-01-24       Impact factor: 22.113

8.  Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

Authors:  Theresa Hahn; Philip L McCarthy; Mei-Jie Zhang; Dan Wang; Mukta Arora; Haydar Frangoul; Robert Peter Gale; Gregory A Hale; John Horan; Luis Isola; Richard T Maziarz; Jon J van Rood; Vikas Gupta; Joerg Halter; Vijay Reddy; Pierre Tiberghien; Mark Litzow; Claudio Anasetti; Stephen Pavletic; Olle Ringdén
Journal:  J Clin Oncol       Date:  2008-11-03       Impact factor: 44.544

9.  Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Aazim K Omer; Daniel J Weisdorf; Aleksandr Lazaryan; Ryan Shanley; Bruce R Blazar; Margaret L MacMillan; Claudio Brunstein; Nelli Bejanyan; Mukta Arora
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-29       Impact factor: 5.742

10.  Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.

Authors:  Stella M Davies; Dan Wang; Tao Wang; Muhkta Arora; Olle Ringden; Claudio Anasetti; Steven Pavletic; James Casper; Margaret L Macmillan; Jean Sanders; Donna Wall; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.